Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 1, 2004, Pages 117-128

  Zanzonico, Pat ^a   O'Donoghue, Joseph ^a   Chapman, J Donald ^b   Schneider, Richard ^b   Cai, Shangde ^a   Larson, Steven ^a   Wen, Bixiu ^a   Chen, Yuchun ^a   Finn, Ronald ^a   Ruan, Shutian ^a   Gerweck, Leo ^c   Humm, John ^a   Ling, Clifton ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

FMISO; IAZG; MicroPET; Tumor hypoxia

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 2 NITROIMIDAZOLE; FLUORINE DERIVATIVE; FLUORODEOXYGLUCOSE F 18; IODINE 124; IODOAZOMYCIN GALACTOSIDE I 124; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BREAST TUMOR; CANCER SCINTISCANNING; CELL STRAIN; CELL STRAIN MCA; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG LIVER LEVEL; DRUG MUSCLE LEVEL; DRUG UPTAKE; FEMALE; FIBROSARCOMA; HEART; HISTOPATHOLOGY; HYPOXEMIA; HYPOXIA; IMAGING SYSTEM; IMPLANTATION; INJECTION; INTESTINE; ISOTOPE LABELING; LUNG; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; SENSOR; STOMACH; TISSUE OXYGENATION; TUMOR HYPOXIA; TUMOR VOLUME;

ANIMALS; CELL HYPOXIA; CELL LINE, TUMOR; FEMALE; FIBROSARCOMA; MAMMARY NEOPLASMS, ANIMAL; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C3H; MISONIDAZOLE; MONOSACCHARIDES; NITROIMIDAZOLES; ORGAN SPECIFICITY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1642512305     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1322-y     Document Type: Article

References (28)

1. Thomlinson R, Gray L. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955; 9:539-549.
2. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996; 41:31-39.
3. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993; 26:45-50.
4. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, Dewhirst MW. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996; 56:941-943.
5. Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, Hanks GE. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiother Oncol 1998; 46:229-237.
6. Urtasun RC, Parliament MB, McEwan AJ, Mercer JR, Mannan RH, Wiebe LI, Morin C, Chapman JD. Measurement of hypoxia in human tumours by non-invasive SPECT imaging of iodoazomycin arabinoside. Br J Cancer 1996; 74 Suppl 27:S209-S212.
7. Ballinger JR. Imaging hypoxia in tumors. Semin Nucl Med 2001; 31:321-329.
8. 18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 1996; 36:417-428.
9. Lehtiö K, Oikonen V, Gronroos T, Eskola O, Kalliokoski K, Bergman J, Solin O, Grenman R, Nuutila P, Minn H. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET. J Nucl Med 2001; 42:1643-1652.
10. 18F] EF1. J Nucl Med 2000; 41:327-336.
11. Evans SM, Hahn SM, Magarelli DP, Koch CJ. Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation. Am J Clin Oncol 2001; 24:467-472.
12. 18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure. Appl Radiat Isot 2001; 54:73-80.
13. 18F labeled fluoroazomycin arabinoside (FAZA): imaging tumor hypoxia with improved biokinetics. J Nucl Med 2002; 43 (Suppl):278P.
14. 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J Nucl Med 1999; 40:177-183.
15. Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, Dempsey JF, Perez CA, Purdy JA, Welch MJ. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2001; 49:1171-1182.
16. 60Cu-ATSM. Eur J Nucl Med Mol Imaging 2003; 30:844-850.
17. 60Cu-ATSM: relationship to therapeutic response-a preliminary report. Int J Radiat Oncol Biol Phys 2003; 55:1233-1238.
18. Chapman J, Lee J, Meeker B. Adduct formation by 2-nitroimidazole drugs in mammalian cells: optimization of markers for tissue oxygenation. In: Adams G, ed. Selective activation of drugs by redox processes. New York: Plenum Press; 1990: 313-323.
19. Seddon BM, Honess DJ, Vojnovic B, Tozer GM, Workman P. Measurement of tumor oxygenation: in vivo comparison of a luminescence fiber-optic sensor and a polarographic needle electrode in the P22 tumor. Radiat Res 2001; 155:837-846.
20. Urano M, Chen Y, Humm J, Koutcher JA, Zanzonico P, Ling C. Measurements of tissue oxygen tension using a time-resolved luminescence-based optical Oxylite probe: comparison with a paired survival assay. Radiat Res 2002; 167-173.
21. 18F]fluoromisonidazole). Pharm Res 1994; 11:466-469.
22. Schneider R, Englehardt E, Stobbe C, Fenning M, Chapman J. The synthesis and radiolabeling of novel markers of tissue hypoxia of the iodinated azomycin nucleoside class. J Label Compd Radiopharm 1997; XXXIX:541-557.
23. Rasey JS, Koh WJ, Grierson JR, Grunbaum Z, Krohn KA. Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia. Int J Radiat Oncol Biol Phys 1989; 17:985-991.
24. 99mTc]HL-91: correlation with microelectrode measurements. J Nucl Med 2001; 42:337-344.
25. 2 by EPR oximetry in rodents: effects of anesthesia, ischemia, and breathing gas. Brain Res 1995; 685:91-98.
26. Menke H, Vaupel P. Effect of injectable or inhalational anesthetics and of neuroleptic neuroleptanalgesic and sedative agents on tumor blood flow. Radiat Res 1988; 114:64-76.
27. Pentlow KS, Graham MC, Lambrecht RM, Cheung NK, Larson SM. Quantitative imaging of 1-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy. Med Phys 1991; 18:357-366.
28. Pentlow KS, Graham MC, Lambrecht RM, Daghighian F, Bacharach SL, Bendriem B, Finn RD, Jordan K, Kalaigian H, Karp JS, Robeson WR, Larson SM. Quantitative imaging of iodine-124 with PET J Nucl Med 1996; 37:1557-1562.